1 Glucagon Drug Market Overview 1.1 Product Overview and Scope of Glucagon Drug 1.2 Glucagon Drug Segment by Type 1.2.1 Global Glucagon Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Inject Glucagon 1.2.3 Nasal Glucagon 1.3 Glucagon Drug Segment by Application 1.3.1 Global Glucagon Drug Sales Comparison by Application: (2021-2027) 1.3.2 Emergency Kits 1.3.3 General Use 1.3.4 Diagnostic & Motility 1.3.5 Cardiogenic Shock 1.3.6 Others 1.4 Global Glucagon Drug Market Size Estimates and Forecasts 1.4.1 Global Glucagon Drug Revenue 2016-2027 1.4.2 Global Glucagon Drug Sales 2016-2027 1.4.3 Glucagon Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Glucagon Drug Market Competition by Manufacturers 2.1 Global Glucagon Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Glucagon Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Glucagon Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Glucagon Drug Manufacturing Sites, Area Served, Product Type 2.5 Glucagon Drug Market Competitive Situation and Trends 2.5.1 Glucagon Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Glucagon Drug Players Market Share by Revenue 2.5.3 Global Glucagon Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Glucagon Drug Retrospective Market Scenario by Region 3.1 Global Glucagon Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Glucagon Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Glucagon Drug Market Facts & Figures by Country 3.3.1 North America Glucagon Drug Sales by Country 3.3.2 North America Glucagon Drug Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Glucagon Drug Market Facts & Figures by Country 3.4.1 Europe Glucagon Drug Sales by Country 3.4.2 Europe Glucagon Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Glucagon Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Glucagon Drug Sales by Region 3.5.2 Asia Pacific Glucagon Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Glucagon Drug Market Facts & Figures by Country 3.6.1 Latin America Glucagon Drug Sales by Country 3.6.2 Latin America Glucagon Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Glucagon Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Glucagon Drug Sales by Country 3.7.2 Middle East and Africa Glucagon Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Glucagon Drug Historic Market Analysis by Type 4.1 Global Glucagon Drug Sales Market Share by Type (2016-2021) 4.2 Global Glucagon Drug Revenue Market Share by Type (2016-2021) 4.3 Global Glucagon Drug Price by Type (2016-2021) 5 Global Glucagon Drug Historic Market Analysis by Application 5.1 Global Glucagon Drug Sales Market Share by Application (2016-2021) 5.2 Global Glucagon Drug Revenue Market Share by Application (2016-2021) 5.3 Global Glucagon Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Novo Nordisk 6.1.1 Novo Nordisk Corporation Information 6.1.2 Novo Nordisk Description and Business Overview 6.1.3 Novo Nordisk Glucagon Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Novo Nordisk Glucagon Drug Product Portfolio 6.1.5 Novo Nordisk Recent Developments/Updates 6.2 Eli Lilly 6.2.1 Eli Lilly Corporation Information 6.2.2 Eli Lilly Description and Business Overview 6.2.3 Eli Lilly Glucagon Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Eli Lilly Glucagon Drug Product Portfolio 6.2.5 Eli Lilly Recent Developments/Updates 6.3 Fresenius Kabi 6.3.1 Fresenius Kabi Corporation Information 6.3.2 Fresenius Kabi Description and Business Overview 6.3.3 Fresenius Kabi Glucagon Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Fresenius Kabi Glucagon Drug Product Portfolio 6.3.5 Fresenius Kabi Recent Developments/Updates 6.4 Torrent Labs 6.4.1 Torrent Labs Corporation Information 6.4.2 Torrent Labs Description and Business Overview 6.4.3 Torrent Labs Glucagon Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Torrent Labs Glucagon Drug Product Portfolio 6.4.5 Torrent Labs Recent Developments/Updates 7 Glucagon Drug Manufacturing Cost Analysis 7.1 Glucagon Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Glucagon Drug 7.4 Glucagon Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Glucagon Drug Distributors List 8.3 Glucagon Drug Customers 9 Glucagon Drug Market Dynamics 9.1 Glucagon Drug Industry Trends 9.2 Glucagon Drug Growth Drivers 9.3 Glucagon Drug Market Challenges 9.4 Glucagon Drug Market Restraints 10 Global Market Forecast 10.1 Glucagon Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Glucagon Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Glucagon Drug by Type (2022-2027) 10.2 Glucagon Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Glucagon Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Glucagon Drug by Application (2022-2027) 10.3 Glucagon Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Glucagon Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Glucagon Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Glucagon Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Glucagon Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Glucagon Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Glucagon Drug Covered in This Study Table 5. Global Glucagon Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Glucagon Drug Sales Market Share by Manufacturers (2016-2021) Table 7. Global Glucagon Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Glucagon Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Glucagon Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Glucagon Drug Manufacturing Sites and Area Served Table 11. Manufacturers Glucagon Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Glucagon Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Glucagon Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Glucagon Drug Sales Market Share by Region (2016-2021) Table 17. Global Glucagon Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Glucagon Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Glucagon Drug Sales Market Share by Country (2016-2021) Table 20. North America Glucagon Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Glucagon Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Glucagon Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Glucagon Drug Sales Market Share by Country (2016-2021) Table 24. Europe Glucagon Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Glucagon Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Glucagon Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Glucagon Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Glucagon Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Glucagon Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Glucagon Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Glucagon Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Glucagon Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Glucagon Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Glucagon Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Glucagon Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Glucagon Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Glucagon Drug Revenue Market Share by Country (2016-2021) Table 38. Global Glucagon Drug Sales (K Units) by Type (2016-2021) Table 39. Global Glucagon Drug Sales Market Share by Type (2016-2021) Table 40. Global Glucagon Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Glucagon Drug Revenue Share by Type (2016-2021) Table 42. Global Glucagon Drug Price (US$/Unit) by Type (2016-2021) Table 43. Global Glucagon Drug Sales (K Units) by Application (2016-2021) Table 44. Global Glucagon Drug Sales Market Share by Application (2016-2021) Table 45. Global Glucagon Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Glucagon Drug Revenue Share by Application (2016-2021) Table 47. Global Glucagon Drug Price (US$/Unit) by Application (2016-2021) Table 48. Novo Nordisk Corporation Information Table 49. Novo Nordisk Description and Business Overview Table 50. Novo Nordisk Glucagon Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Novo Nordisk Glucagon Drug Product Table 52. Novo Nordisk Recent Developments/Updates Table 53. Eli Lilly Corporation Information Table 54. Eli Lilly Description and Business Overview Table 55. Eli Lilly Glucagon Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Eli Lilly Glucagon Drug Product Table 57. Eli Lilly Recent Developments/Updates Table 58. Fresenius Kabi Corporation Information Table 59. Fresenius Kabi Description and Business Overview Table 60. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Fresenius Kabi Glucagon Drug Product Table 62. Fresenius Kabi Recent Developments/Updates Table 63. Torrent Labs Corporation Information Table 64. Torrent Labs Description and Business Overview Table 65. Torrent Labs Glucagon Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Torrent Labs Glucagon Drug Product Table 67. Torrent Labs Recent Developments/Updates Table 68. Production Base and Market Concentration Rate of Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Glucagon Drug Distributors List Table 71. Glucagon Drug Customers List Table 72. Glucagon Drug Market Trends Table 73. Glucagon Drug Growth Drivers Table 74. Glucagon Drug Market Challenges Table 75. Glucagon Drug Market Restraints Table 76. Global Glucagon Drug Sales Forecast by Type (2022-2027) & (K Units) Table 77. Global Glucagon Drug Sales Market Share Forecast by Type (2022-2027) Table 78. Global Glucagon Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 79. Global Glucagon Drug Revenue Market Share Forecast by Type (2022-2027) Table 80. Global Glucagon Drug Sales Forecast by Application (2022-2027) & (K Units) Table 81. Global Glucagon Drug Sales Market Share Forecast by Application (2022-2027) Table 82. Global Glucagon Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 83. Global Glucagon Drug Revenue Market Share Forecast by Application (2022-2027) Table 84. Global Glucagon Drug Sales Forecast by Region (2022-2027) & (K Units) Table 85. Global Glucagon Drug Sales Market Share Forecast by Region (2022-2027) Table 86. Global Glucagon Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 87. Global Glucagon Drug Revenue Market Share Forecast by Region (2022-2027) Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Glucagon Drug Figure 2. Global Glucagon Drug Market Share by Type in 2020 & 2027 Figure 3. Inject Glucagon Product Picture Figure 4. Nasal Glucagon Product Picture Figure 5. Global Glucagon Drug Market Share by Application in 2020 & 2027 Figure 6. Emergency Kits Figure 7. General Use Figure 8. Diagnostic & Motility Figure 9. Cardiogenic Shock Figure 10. Others Figure 11. Global Glucagon Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Glucagon Drug Market Size 2016-2027 (US$ Million) Figure 13. Global Glucagon Drug Sales 2016-2027 (K Units) Figure 14. Global Glucagon Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Glucagon Drug Sales Share by Manufacturers in 2020 Figure 16. Global Glucagon Drug Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Glucagon Drug Players: Market Share by Revenue in 2020 Figure 18. Glucagon Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Glucagon Drug Sales Market Share by Region (2016-2021) Figure 20. Global Glucagon Drug Sales Market Share by Region in 2020 Figure 21. Global Glucagon Drug Revenue Market Share by Region (2016-2021) Figure 22. Global Glucagon Drug Revenue Market Share by Region in 2020 Figure 23. United States Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. China Taiwan Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Colombia Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. UAE Glucagon Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Glucagon Drug by Type (2016-2021) Figure 47. Sales Market Share of Glucagon Drug by Application (2016-2021) Figure 48. Sales Market Share of Glucagon Drug by Application in 2020 Figure 49. Revenue Share of Glucagon Drug by Application (2016-2021) Figure 50. Revenue Share of Glucagon Drug by Application in 2020 Figure 51. Manufacturing Cost Structure of Glucagon Drug Figure 52. Manufacturing Process Analysis of Glucagon Drug Figure 53. Glucagon Drug Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Novo Nordisk Eli Lilly Fresenius Kabi Torrent Labs